NO930709D0 - Nye cholecystokinin-antagonister, deres fremstilling og terapeutiske anvendelse - Google Patents

Nye cholecystokinin-antagonister, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO930709D0
NO930709D0 NO930709A NO930709A NO930709D0 NO 930709 D0 NO930709 D0 NO 930709D0 NO 930709 A NO930709 A NO 930709A NO 930709 A NO930709 A NO 930709A NO 930709 D0 NO930709 D0 NO 930709D0
Authority
NO
Norway
Prior art keywords
preparation
new
therapeutic application
cholecystokinin antagonists
cholecystokinin
Prior art date
Application number
NO930709A
Other languages
English (en)
Other versions
NO930709L (no
NO312298B1 (no
Inventor
David Christopher Horwell
David Charles Rees
William Howard Roark
Bruce David Roth
Janak Khimchand Padia
Juergen Kleinschroth
Reginald Stewart Richardson
Edward Roberts
Ann Holmes
Bharat Kalidas Trivedi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO930709D0 publication Critical patent/NO930709D0/no
Publication of NO930709L publication Critical patent/NO930709L/no
Publication of NO312298B1 publication Critical patent/NO312298B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Addiction (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
NO19930709A 1990-08-31 1993-02-26 Analogifremgangsmåte for fremstilling av terapeutisk aktive indolderivater NO312298B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57662890A 1990-08-31 1990-08-31
US72665591A 1991-07-12 1991-07-12
PCT/US1991/006180 WO1992004045A1 (en) 1990-08-31 1991-08-29 Novel cholecystokinin antagonists, their preparation and therapeutic use

Publications (3)

Publication Number Publication Date
NO930709D0 true NO930709D0 (no) 1993-02-26
NO930709L NO930709L (no) 1993-04-15
NO312298B1 NO312298B1 (no) 2002-04-22

Family

ID=27077012

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19930709A NO312298B1 (no) 1990-08-31 1993-02-26 Analogifremgangsmåte for fremstilling av terapeutisk aktive indolderivater

Country Status (9)

Country Link
EP (1) EP0547178A4 (no)
JP (1) JPH06502627A (no)
KR (1) KR100222634B1 (no)
CA (1) CA2088195A1 (no)
IE (1) IE67290B1 (no)
NO (1) NO312298B1 (no)
NZ (1) NZ239595A (no)
PT (1) PT98842B (no)
WO (1) WO1992004045A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217957A (en) * 1991-08-20 1993-06-08 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5380872A (en) * 1992-07-14 1995-01-10 Glaxo Inc. Modulators of cholecystokinin
WO1994018229A1 (en) * 1993-02-03 1994-08-18 Fisons Corporation 1,2,4-triazinone derivatives and their use in therapy
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
ATE311383T1 (de) 1996-08-22 2005-12-15 Warner Lambert Co Nicht-peptidische bombesin rezeptor antagonisten
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
US6846836B2 (en) 2003-04-18 2005-01-25 Bristol-Myers Squibb Company N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
WO2005077344A2 (en) 2003-08-29 2005-08-25 The Brigham And Women's Hospital, Inc. Hydantoin derivatives as inhibitors of cellular necrosis
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
EP2066329B1 (en) * 2006-09-15 2017-09-06 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cyclobutylmethylamines
AU2009329879A1 (en) 2008-12-23 2011-08-11 President And Fellows Of Harvard College Small molecule inhibitors of necroptosis
GB0919194D0 (en) 2009-11-02 2009-12-16 Lytix Biopharma As Compounds
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
EP3229807A4 (en) 2014-12-11 2018-10-17 President and Fellows of Harvard College Inhibitors of cellular necrosis and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757151A (en) * 1985-11-14 1988-07-12 Warner-Lambert Company 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
CA1291031C (en) * 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
FR2606963B1 (fr) * 1986-11-14 1989-01-13 Cit Alcatel Boitier de repeteur sous-marin
EP0336356A3 (en) * 1988-04-05 1991-09-25 Abbott Laboratories Derivatives of tryptophan as cck antagonists
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal

Also Published As

Publication number Publication date
IE913077A1 (en) 1992-03-11
NO930709L (no) 1993-04-15
AU8749291A (en) 1992-03-30
IE67290B1 (en) 1996-03-20
NO312298B1 (no) 2002-04-22
AU651390B2 (en) 1994-07-21
NZ239595A (en) 1994-06-27
JPH06502627A (ja) 1994-03-24
CA2088195A1 (en) 1992-03-01
WO1992004045A1 (en) 1992-03-19
KR100222634B1 (ko) 1999-10-01
EP0547178A4 (en) 1994-07-06
PT98842B (pt) 1999-01-29
PT98842A (pt) 1992-08-31
KR930703349A (ko) 1993-11-29
EP0547178A1 (en) 1993-06-23

Similar Documents

Publication Publication Date Title
NO933690L (no) Nye tiopyranopyrrolderivater og deres fremstilling
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK0523183T3 (da) Mikrosfærer, deres fremstilling og anvendelse
NO924775D0 (no) Substituerte benzimidazoler, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
NO930709L (no) Nye cholecystokinin-antagonister, deres fremstilling og terapeutiske anvendelse
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
NO914288L (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
DK435289D0 (da) Piperazindioner, deres fremstilling og anvendelse
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
ITMI911470A1 (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO931364D0 (no) Tachykinin reseptorantagonister, isokinoloner og deres fremstilling
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO922992L (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
DK196389D0 (da) N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse
NO921723D0 (no) Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse
NO942322L (no) Nye 3-halogen-5-halogenmetyl-2-oksazolidinoner og deres anvendelse som mikrobicider
DK55893D0 (da) Nye receptoraktive forbindelser, deres fremstilling og anvendelse
DK123188D0 (da) Nye oxadiazolylforbindelser, deres fremstilling og anvendelse
NO904168L (no) Nye imidazolpropanamidderivater, deres fremstilling og anvendelse.
NO933596D0 (no) Nye 2-spirocyklopropylcefalosporinsulfonderivater og deres fremstilling

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees